Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

45

Revenue 2017

Zytiga

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Zytiga was produced by Janssen.

J&J puts pressure on rivals with new Erleada okay in prostate cancer

J&J puts pressure on rivals with new Erleada okay in prostate cancer

Androgen inhibitor Erleada (apalutamide) is J&J’s follow-up up to big-selling prostate cancer therapy Zytiga (abiraterone acetate), which has been in a market battle for years with Xtandi ... and Pfizer’s drug as it tries to position Erleada as a

Trial backs role for Lynparza in second-line prostate cancer

Trial backs role for Lynparza in second-line prostate cancer In the 340-patient trial,   Lynparza was compared to hormonal treatment with Pfizer’s Xtandi (enzalutamide) or Johnson &Johnson’s Zytiga (abiraterone acetate) in this second-line setting, focusing on patients ... AZ is also conducting a phase 3

Bayer bags FDA nod for early prostate cancer drug darolutamide

Bayer bags FDA nod for early prostate cancer drug darolutamide Now its approved, Nubeqa will go head-to-head in the non-metastatic CRPC market with J&J’s Erleada (apalutamide) – a follow-up to its Zytiga (abiraterone) brand which is ... Zytiga is only approved for metastatic CRPC and, as Xtandi and Erleada were

Bayer gains FDA priority review for prostate cancer drug

Bayer gains FDA priority review for prostate cancer drug Once approved, the drug will go up against Johnson &Johnson’s Zytiga (with the first generics now reaching the market), its follow-up Erleada, and Pfizer/Astellas' Xtandi. ... The big question is whether that will be enough to differentiate the drug

Bayer, Orion prep challenge in prostate cancer market

Bayer, Orion prep challenge in prostate cancer market New arrival will face tough competition, not least generic Zytiga. Bayer and Orion have put some meat on the bones of their phase 3 trial of darolutamide in non-metastatic ... Darolutamide is facing some entrenched, heavyweight rivals in the market for

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics